Back to results
US 11,229,703 B2Granted
Radiotherapy improvements
AssigneeNoxopharm Limited
InventorGraham Kelly
Life of this patent
Estimating the term…
Abstract
A method for inducing abscopal, complete or partial response to radiotherapy comprising administering isoflavone compounds and irradiating with a cytotoxic dose of ionising radiation so that fewer than all of the plurality of tumours are irradiated.
Claims21
A method for inducing an abscopal response to radiotherapy in an individual, including:
- irradiating an individual having a plurality of tumors, and who has received idronoxil, with a cytotoxic dose of ionising radiation so that fewer than all of the plurality of tumors are irradiated, thereby resulting in the individual having irradiated and non-irradiated tumors,
- wherein at least one of the tumors is a primary tumor, and at least one of the tumors is a metastatic or secondary tumor of a primary tumor;
- wherein at least one of the primary, or metastatic or secondary tumors, is a prostate tumor;
- wherein idronoxil is administered to the individual about 12 to 24 hours before irradiating the individual and,
- wherein idronoxil is administered for 13 consecutive days, including 1 day before radiotherapy, on each day of radiotherapy, wherein the individual receives radiotherapy in 5 fractionated doses over 5 consecutive days, and on each day for 7 days following radiotherapy;
- wherein one or more non-irradiated tumors regress following administration of idronoxil and the irradiation of the individual, thereby inducing an abscopal response to radiotherapy in the individual.
3 more elements
Dependencies are inferred from the claim text.